Alamo Pharma Services Chief Operating Officer to Share Insights During CBI’s 6th Annual Bio/Pharma Product Forecasting & Analytics Summit

DOYLESTOWN, Pa. (June 14, 2017) – Peter Marchesini, Chief Operating Officer of Alamo Pharma Services (“Alamo”), will participate in CBI’s sixth annual “Bio/Pharma Product Forecasting and Analytics Summit” taking place in Philadelphia on June 15 and 16, 2017. The focus of the summit is to help attendees improve forecasting to optimize revenue potential for pipeline and inline products.

Alamo Pharma Services and BexR Logistix Add Top Executive to Help with Sales Operations and Business Development Efforts

SAN ANTONIO (June 8, 2017) – Alamo Pharma Services, Inc. (“Alamo”) and BexR Logistix, LLC (“BexR”) continue to grow with the addition of Thomas M. (Tom) Sottile as Executive Director, Sales and Business Development. Tom will contribute to the sales operations and business development efforts for two of the Mission Family of Companies. Having been in the industry for more than 25 years, Sottile has experienced career growth on both the manufacturing and services sides of the pharmaceutical industry.

Alamo Pharma Services Sales Training Leader to Participate in 2017 LTEN Conference Panel Discussion

DOYLESTOWN, PA (June 5, 2017) – Denise Fullowan, Executive Director, Training & Development of Alamo Pharma Services, Inc. (“Alamo”), will participate in the Life Sciences Trainers & Educators Network (“LTEN”) Conference, in Nashville, Tennessee, on Tuesday, June 6, 2017. The conference, which commences on June 5 and runs through June 8, is being held for its 46th year and is the only conference developed entirely by and for life sciences trainers.

ProSolus Seeks Higher Utilization of Transdermal Drug Delivery Technology

MIAMI, Fla. (April 25, 2017) – ProSolus, Inc. (“ProSolus”) is doubling down on its efforts to expand the utilization of transdermal drug delivery technologies. Today Mission Pharmacal Company (“Mission”) and ProSolus announced the expanded manufacturing capabilities of ProSolus and an increased emphasis on the company’s overall commercialization efforts.

Alamo Pharma Services and BexR Logistix Leaders to Participate in the Synergistix Solutions through Partnerships Conference Panel Discussions

SAN ANTONIO (March 7, 2017) – Peter Marchesini, Chief Operating Officer of Alamo Pharma Services, Inc. (“Alamo”), and Daniel J. Harmon, Jr., General Manager and Vice President of Business Development at BexR Logistix, LLC (“BexR”), will participate in the 13th annual Synergistix Solutions through Partnerships Conference in Pompano Beach, Florida, March 8-10, 2017. The conference is an invitation only event for pharmaceutical and life sciences executives, that focuses on key aspects of product commercialization and operations in the pharmaceutical and medical device arena.

Napo Pharmaceuticals Signs Agreement with Alamo Pharma Services to Launch National Sales Force for Mytesi™

SAN FRANCISCO, CA (February 28, 2017) — Napo Pharmaceuticals, Inc., a company focused on the development and commercialization of proprietary pharmaceuticals for the global marketplace from plants traditionally used in rainforest areas, announces today that it has signed an agreement with Alamo Pharma Services, Inc. for the establishment and management of a national sales team for Mytesi™ (formerly known as Fulyzaq). Mytesi™, launched by Napo in October 2016, is approved by the U.S.

Mission Pharmacal Announces Continued Support of March of Dimes® and Signature Fundraiser, March for Babies®

SAN ANTONIO (February 9, 2017) – Mission Pharmacal Company (“Mission”) celebrated the kick off of its 2017 fundraising campaign in support of the March of Dimes Foundation®, and its signature fundraiser March for Babies. The March of Dimes is committed to a world in which every baby gets a fighting chance. The company has been a national supporter of the March of Dimes since 2010 and during that time has contributed more than $2.1 million dollars to the organization through corporate sponsorship and fundraising efforts.

Alamo Pharma Services Announces Launch of New Website

DOYLESTOWN, PA. (February 7, 2017) — Alamo Pharma Services, Inc. (“Alamo”), a leading pharmaceutical commercial solutions provider and member of the Mission Family of Companies, today announced the launch of their updated website

Mission Pharmacal Invests In Elements of Genius In Advance of Upcoming “Wellnest” Launch

SAN ANTONIO (January 24, 2017) – Mission Pharmacal Company (“Mission”) today announced it has invested in the company Elements of Genius (“Elements”) and their flagship product Wellnest™. This investment comes as Elements prepares for the July 1, 2017, launch of Wellnest – a mobile device worn by seniors and designed to enhance the user’s health and wellness – further expanding Mission’s reach into the senior care market.

Mission Pharmacal Business Development Team Returns to J.P. Morgan Healthcare Conference

SAN ANTONIO (January 9, 2017) – Today marks the opening of the 35th annual J.P.